Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop

Journal of Clinical Investigation

Volumn 112, Issue 6, 2003, Pages 863-871

  Kook, Hyun ^a   Lepore, John J ^a   Gitler, Aaron D ^a   Lu, Min Min ^a   Yung, Wendy Wing Man ^b   Mackay, Joel ^b   Zhou, Rong ^c   Ferrari, Victor ^a   Gruber, Peter ^d   Epstein, Jonathan A ^a,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e 954 Biomedical Research Building II ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; HOMEODOMAIN PROTEIN; ISOPRENALINE; MUTANT PROTEIN; PROTEIN HOP; SERUM RESPONSE FACTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; HOP PROTEIN, MOUSE; REPRESSOR PROTEIN;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO CELL; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE REPRESSION; HEART DEVELOPMENT; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; MORTALITY; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; ANIMAL; CARDIOMEGALY; CELL LINE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEART MUSCLE; HEMODYNAMICS; HUMAN; METABOLISM; PATHOLOGY; SURVIVAL RATE;

ANIMALS; CARDIOMEGALY; CARDIOTONIC AGENTS; CELL LINE; GENE EXPRESSION REGULATION; HEMODYNAMIC PROCESSES; HISTONE DEACETYLASES; HOMEODOMAIN PROTEINS; HUMANS; ISOPROTERENOL; MICE; MICE, TRANSGENIC; MYOCARDIUM; REPRESSOR PROTEINS; SERUM RESPONSE FACTOR; SURVIVAL RATE; TRANSCRIPTION, GENETIC;

EID: 85047694248     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19137     Document Type: Article

References (44)

1. Braunwald, E. 2001. Heart disease: a textbook of cardiovascular medicine. Philadelphia: W.B. Saunders. ch. 13.
2. Marks, A.R. 2003. Calcium and the heart: a question of life and death. J. Clin. Invest. 111:597-600. doi:10.1172/JCI200318067.
3. Epstein, N.D., and Davis, J.S. 2003. Sensing stretch is fundamental. Cell. 112:147-150.
4. McKinsey, T.A., and Olson, E.N. 1999. Cardiac hypertrophy: sorting out the circuitry. Curr Opin. Genet. Dev. 9:267-274.
5. Braunwald, E. 1997. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337:1360-1369.
6. Seidman, J.G., and Seidman, C. 2001. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 104:557-567.
7. Rockman, H.A., Koch, W.J., and Lefkowitz, R.J. 1997. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. Am. J. Physiol. 272:H1553-H1559.
8. Knoll, R., et al. 2002. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell. 111:943-955
9. Hunter, J.J., and Chien, K.R. 1999. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341:1276-1283.
10. Molkentin, J.D., et al. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:215-228.
11. McKinsey, T.A., Zhang, C.L., and Olson, E.N. 2000. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci U. S. A. 97:14400-14405.
12. Zhang, C.L., et al. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 110:479-488.
13. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599-606.
14. Jenuwein, T., and Allis, C.D. 2001. Translating the histone code. Science. 293:1074-1080.
15. Fischle, W., Wang, Y., and Allis, C.D. 2003. Histone and chromatin crosstalk. Curr. Opin. Cell Biol. 15:172-183.
16. Minucci, S., Nervi, C., Lo Coco, F., and Pelicci, P.G. 2001. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? Oncogene. 20:3110-3115.
17. Vigushin, D.M., and Coombes, R.C. 2002. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs. 13:1-13.
18. Kwon, H.J., Kim, M., and Kim, D.H. 2003. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J. Biochem. Mol. Biol. 36:110-119.
19. Chen, F., et al. 2002. Hop is an unusual homeobox gene that modulates cardiac development. Cell. 110:713-723.
20. Shin, C.H., et al. 2002. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell. 110:725-735.
21. Gulick, J., Subramaniam, A., Neumann, J., and Robbins, J. 1991. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J. Biol. Chem. 266:9180-9185.
22. Zhou, R., Pickup, S., Glickson, J., Scott, C., and Ferarri, V.A. 2003. Assessment of global and regional myocardial function in the mouse using cine and tagged MRI. Magn. Reson. Med. 49:760-764.
23. Kuwahara, K., et al. 2001. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol. Cell Biol. 21:2085-2097.
24. Strobeck, M., et al. 2001. Binding of serum response factor co CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells. J. Biol. Chem. 276:16418-16424.
25. Qiu, P., and Li, L. 2002. Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. Circ. Res. 90:858-865.
26. Palermo, J., Gulick, J., Colbert, M., Fewell, J., and Robbins, J. 1996. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ. Res. 78:504-509.
27. Huang, W.Y., Aramburu, J., Douglas, P.S., and Izumo, S. 2000. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat. Med. 6:482-483.
28. Wang, D., et al. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 105:851-862.
29. Yoshida, M., Kijima, M., Akita, M., and Beppu, T. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:17174-17179.
30. Nervi, C., et al. 2001. Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity. Cancer Res. 61:1247-1249.
31. Gottlicher, M., et al. 2001. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20:6969-6978
32. Bueno, O.F., et al. 2002. Impaired cardiac hypertrophic response in calcineurin A beta-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 99:4586-4591.
33. Friddle, C.J., Koga, T., Rubin, E.M., and Bristow, J. 2000. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 97:6745-6750.
34. Soonpaa, M.H., and Field, L.J. 1994. Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am. J. Physiol. 266:H1439-H1445.
35. Chien, K.R. 2000. Genomic circuits and the integrative biology of cardiac diseases. Nature. 407:227-232.
36. McKinsey, T.A., Zhang, C.L., and Olson, E.N. 2000 Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. U. S. A. 97:14400-14405.
37. Passier, R., et al. 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105:1395-1406.
38. Antos, C.L., et al. 2003. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem. 278:28930-28937.
39. Zhang, X., et al. 2001. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am. J. Physiol. Heart Circ. Physiol. 280:H1782-H1792.
40. Zhang, X., et al. 2001. Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J. Biol. Chem. 276:40033-40040.
41. Norman, C., Runswick, M., Pollock, R., and Treisman, R. 1988. Isolation and properties of cDNA clones encoding SRF, a transcription factor chat binds to the c-fos serum response element. Cell. 55:989-1003.
42. Liu, Z.P., and Olson, E.N. 2002. Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase. Proc. Natl. Acad. Sci. U. S. A. 99:2043-2048.
43. Petti, M.C., et al. 2002. Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies. Blood. 100:1065-1067.
44. Fabian, C.J., and Kimler, B. F. 2001. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention. Ann. N. Y. Acad. Sci. 952:44-59.